DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Clinical trial NCT07162506 · RECRUITING

Trial details

NCT number: NCT07162506
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2025-11-03
Primary completion: 2027-08-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.